Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Diamond

Showing results (731-740 of 735) with videos related to

Pageof 74
Sort By:
You have reached the last page of results.This site can display upto 735 results.
The New England Journal of Medicine|May 20, 2017
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH AntagonistHugh S Taylor, Linda C Giudice, Bruce A Lessey, et al.
Lancet (London, England)|December 24, 2014
Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trialDavid F Garway-Heath, David P Crabb, Catey Bunce, et al.
Journal of Women'S Health (2002)|January 13, 2023
A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF RegistryRaymond M Anchan, Daniel Wojdyla, Pietro Bortoletto, et al.
Obstetrics and Gynecology|June 12, 2018
Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension StudiesEric Surrey, Hugh S Taylor, Linda Giudice, et al.
American Journal of Obstetrics and Gynecology|May 27, 2023
Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroidsRaymond M Anchan, James B Spies, Shuaiqi Zhang, et al.
Pageof 74

Showing results (731-740 of 735) with videos related to

Sort By:
Pageof 74
You have reached the last page of results.This site can display upto 735 results.
The New England Journal of Medicine|May 20, 2017
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH AntagonistHugh S Taylor, Linda C Giudice, Bruce A Lessey, et al.
Lancet (London, England)|December 24, 2014
Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trialDavid F Garway-Heath, David P Crabb, Catey Bunce, et al.
Journal of Women'S Health (2002)|January 13, 2023
A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF RegistryRaymond M Anchan, Daniel Wojdyla, Pietro Bortoletto, et al.
Obstetrics and Gynecology|June 12, 2018
Long-Term Outcomes of Elagolix in Women With Endometriosis: Results From Two Extension StudiesEric Surrey, Hugh S Taylor, Linda Giudice, et al.
American Journal of Obstetrics and Gynecology|May 27, 2023
Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroidsRaymond M Anchan, James B Spies, Shuaiqi Zhang, et al.
Pageof 74